Luye Pharma reports stable share capital and issued shares in november

Luye Pharma Group Ltd. reported its monthly return on movements in securities for the period ended November 30, 2025. The company's authorized share capital remained unchanged at 10 bn ordinary shares, with a par value of $0.02, totaling $200m.

Similarly, the total number of issued shares (excluding treasury shares) for Luye Pharma Group Ltd. held steady at 3,994,515,953. There were no movements in issued shares or treasury shares during the month. The company also confirmed no activity in share options or warrants to issue shares.

However, Luye Pharma Group Ltd. has convertible bonds outstanding, with an amount of $180m at the close of the month. These bonds are convertible into ordinary shares at a subscription/conversion price of HK$4.88, potentially allowing for the issuance of up to 288,793,032 shares. No new shares were issued from convertibles during November.